Information Provided By: 
Fly News Breaks for May 26, 2017
SPLK
May 26, 2017 | 07:17 EDT
Canaccord analyst Richard Davis said Splunk shares were higher in anticipation of a perfect quarter and when it didn't materialize, the shares traded lower. The analyst said the company's numbers were solid across the board but its licensing growth of 16% was below expectations due to seasonality. He recommends investors buy the dip as the company's intermediate and long-term outlook is quite attractive. Davis reiterated his Buy rating and $75 price target on Splunk shares.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
